◀ Back to VIP

CD80 — VIP

Text-mined interactions from Literome

Ganea et al., Cell Mol Biol Incl Cyto Enzymol 2003 : In addition, VIP/PACAP reduce the expression of costimulatory molecules ( particularly CD80 and CD86 ) on the antigen presenting cells, and therefore reduce stimulation of antigen-specific CD4+ T cells
Chorny et al., Ann N Y Acad Sci 2006 (Autoimmune Diseases) : In contrast, VIP reduces both CD86 and CD80 expression on lipopolysaccharide (LPS) stimulated DCs, and inhibits the capacity of DCs to induce in vitro or in vivo T cell proliferation
Gonzalez-Rey et al., Curr Pharm Des 2007 : In addition, VIP/PACAP reduce the expression of costimulatory molecules ( particularly CD80 and CD86 ) on the antigen presenting cells, and therefore reduce stimulation of antigen-specific CD4 ( + ) T cells
Lu et al., Int Immunopharmacol 2008 : In the absence of LPS, VIP , in a dose dependent manner, up-regulated the expression of CD80 , CD86, CD54 and CD40, but down-regulated the expression of MHC class II molecule ( Ia ( b ) )